Personome Medicine Profile
Key Indicators
- Authorised Capital ₹ 4.60 M
as on 01-01-2025
- Paid Up Capital ₹ 4.60 M
as on 01-01-2025
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 3.52%
(FY 2022)
- Profit -6.23%
(FY 2022)
- Ebitda -10.63%
(FY 2022)
- Net Worth 1.86%
(FY 2022)
- Total Assets -42.90%
(FY 2022)
About Personome Medicine
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.60 M and a paid-up capital of Rs 4.60 M, as per Ministry of Corporate Affairs (MCA) records.
Sharvari Ausekar and Aniket Ausekar serve as directors at the Company.
- CIN/LLPIN
U73200PN2004PTC019895
- Company No.
019895
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Oct 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Personome Medicine?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharvari Ausekar  | Director | 29-Oct-2004 | Current |
| Aniket Ausekar | Director | 29-Oct-2004 | Current |
Financial Performance of Personome Medicine.
Personome Medicine Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 3.52% increase. The company also saw a slight decrease in profitability, with a 6.23% decrease in profit. The company's net worth moved up by a moderate rise of 1.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Personome Medicine?
In 2022, Personome Medicine had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Evolvus Informatics LlpActive 8 years 4 monthsSharvari Ausekar and Aniket Ausekar are mutual person
Evolvus Technologies Private LimitedActive 12 years 11 monthsSharvari Ausekar and Aniket Ausekar are mutual person
Evolvus Biotech Private LimitedActive 23 years 28 daysSharvari Ausekar and Aniket Ausekar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Personome Medicine?
Unlock and access historical data on people associated with Personome Medicine, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Personome Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Personome Medicine's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
